geo_accession,title,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,taxid_ch1,characteristics_ch1,molecule_ch1,extract_protocol_ch1,description,data_processing,platform_id,contact_name,contact_email,contact_phone,contact_laboratory,contact_department,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,instrument_model,library_selection,library_source,library_strategy,relation,supplementary_file_1,supplementary_file_2,supplementary_file_3,series_id,data_row_count
GSM3440844,GU0700_T,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from renal tumor,Homo sapiens,9606,patient age: 69,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0700_T_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272927,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440844/suppl/GSM3440844_GU0700_T_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440844/suppl/GSM3440844_GU0700_T_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440844/suppl/GSM3440844_GU0700_T_matrix.mtx.gz,GSE121636,0
GSM3440845,GU0715_T,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from renal tumor,Homo sapiens,9606,patient age: 74,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0715_T_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272926,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440845/suppl/GSM3440845_GU0715_T_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440845/suppl/GSM3440845_GU0715_T_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440845/suppl/GSM3440845_GU0715_T_matrix.mtx.gz,GSE121636,0
GSM3440846,GU0744_T,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from renal tumor,Homo sapiens,9606,patient age: 67,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0744_T_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272925,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440846/suppl/GSM3440846_GU0744_T_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440846/suppl/GSM3440846_GU0744_T_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440846/suppl/GSM3440846_GU0744_T_matrix.mtx.gz,GSE121636,0
GSM3440847,GU0700_P,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from peripheral blood,Homo sapiens,9606,patient age: 69,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0700_P_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272924,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440847/suppl/GSM3440847_GU0700_P_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440847/suppl/GSM3440847_GU0700_P_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440847/suppl/GSM3440847_GU0700_P_matrix.mtx.gz,GSE121636,0
GSM3440848,GU0715_P,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from peripheral blood,Homo sapiens,9606,patient age: 74,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0715_P_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272923,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440848/suppl/GSM3440848_GU0715_P_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440848/suppl/GSM3440848_GU0715_P_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440848/suppl/GSM3440848_GU0715_P_matrix.mtx.gz,GSE121636,0
GSM3440849,GU0744_P,Public on Oct 19 2020,Oct 22 2018,Oct 19 2020,SRA,1,CD45+ immune cells from peripheral blood,Homo sapiens,9606,patient age: 67,polyA RNA,"Viable (Hoechst-), immune (CD45+) single-cell suspensions generated from three ccRCC tumor samples and peripheral blood were sorted on a FACS ARIA sorter (BD Biosciences) for lymphoid and myeloid lineages. The cells were sorted into ice-cold 1x PBS + 0.04% non-acetylated bovine-serum albumin (New England BioLabs). Sorted cells were counted and viability as assessed using the MoxiGoII counter (Orflo Technologies). Single cells were re-suspended at 1000 cells/ul with a viability > 90%. Libraries were generated using using the Chromium Single Cell 5-prime Enrichment Kit and sequenced on the Illumina HiSeq 4000",GU0744_P_S1_L001,"10x Data was processed with the Cell Ranger pipeline, version 2.2",GPL20301,"Weizhou,,Zhang",weizhou-zhang@uiowa.edu,3193358214,Zhang Lab,Pathology,The University of Iowa,100 Medical Laboratories,Iowa City,IA,52242,USA,Illumina HiSeq 4000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10272922,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440849/suppl/GSM3440849_GU0744_P_barcodes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440849/suppl/GSM3440849_GU0744_P_genes.tsv.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3440nnn/GSM3440849/suppl/GSM3440849_GU0744_P_matrix.mtx.gz,GSE121636,0
